• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有良好物理化学性质的阿昔洛韦共晶体。

Cocrystals of acyclovir with promising physicochemical properties.

作者信息

Sarkar Anindita, Rohani Sohrab

机构信息

Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, N6A 5B9, Ontario, Canada.

出版信息

J Pharm Sci. 2015 Jan;104(1):98-105. doi: 10.1002/jps.24248. Epub 2014 Nov 18.

DOI:10.1002/jps.24248
PMID:25407552
Abstract

Cocrystal forming ability of antiviral drug acyclovir (ACV) with different coformers was studied. Three cocrystals containing ACV with fumaric acid, malonic acid, and DL-tartaric acid were isolated. Methods of cocrystallization included grinding with dropwise solvent addition and solvent evaporation. The cocrystals were characterized by powder X-ray diffraction, differential scanning calorimetry, and thermogravimetric analysis. The crystal structure of the cocrystal with fumaric acid as conformer was determined by single crystal X-ray diffraction. Formation of supramolecular synthon was observed in the cocrystal. Stability with respect to relative humidity for the three cocrystals was evaluated. The aqueous solubility of the ACV-cocrystal materials was significantly improved with a maximum of malonic acid cocrystal, which was about six times more soluble at 35°C compared with that of parent ACV. The dissolution profile indicates that at any particular dissolution time, the concentration of cocrystals in the solution was higher than that of the parent ACV, and malonic acid cocrystals had a maximum release of about twice than the hydrated ACV.

摘要

研究了抗病毒药物阿昔洛韦(ACV)与不同共形成物的共晶形成能力。分离出了三种含阿昔洛韦与富马酸、丙二酸和DL-酒石酸的共晶。共结晶方法包括滴加溶剂研磨和溶剂蒸发。通过粉末X射线衍射、差示扫描量热法和热重分析对共晶进行了表征。以富马酸为共形成物的共晶的晶体结构通过单晶X射线衍射确定。在共晶中观察到超分子合成子的形成。评估了三种共晶在相对湿度方面的稳定性。ACV-共晶材料的水溶性显著提高,丙二酸共晶的水溶性提高最大,在35°C时其溶解度比母体ACV高约六倍。溶出曲线表明,在任何特定的溶出时间,溶液中共晶的浓度均高于母体ACV,丙二酸共晶的最大释放量约为水合ACV的两倍。

相似文献

1
Cocrystals of acyclovir with promising physicochemical properties.具有良好物理化学性质的阿昔洛韦共晶体。
J Pharm Sci. 2015 Jan;104(1):98-105. doi: 10.1002/jps.24248. Epub 2014 Nov 18.
2
Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.药物-赋形剂相互作用诱导共结晶和无定形化可改善阿昔洛韦的物理性质。
Int J Pharm. 2012 Jan 17;422(1-2):160-9. doi: 10.1016/j.ijpharm.2011.10.046. Epub 2011 Nov 3.
3
Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.制备和改善溶解性能的阿昔洛韦共晶的物理化学特性。
J Pharm Sci. 2013 Nov;102(11):4079-86. doi: 10.1002/jps.23721. Epub 2013 Sep 12.
4
Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids.埃替唑胺三种新型无定型物与脂肪族二元羧酸共晶的结构特征和药物性能。
J Pharm Sci. 2019 Apr;108(4):1476-1485. doi: 10.1016/j.xphs.2018.10.060. Epub 2018 Nov 8.
5
Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.氯诺昔康共晶体的固态操作——物理化学表征
Drug Dev Ind Pharm. 2014 Sep;40(9):1163-72. doi: 10.3109/03639045.2013.804834. Epub 2013 Jul 5.
6
Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.硝呋太尔-对氨基苯甲酸共晶:水稳定性和溶解速率研究。
J Pharm Sci. 2011 Aug;100(8):3233-3244. doi: 10.1002/jps.22546. Epub 2011 Mar 18.
7
Crystal engineering of stable temozolomide cocrystals.稳定替莫唑胺共晶的晶体工程。
Chem Asian J. 2012 Oct;7(10):2274-85. doi: 10.1002/asia.201200205. Epub 2012 May 21.
8
Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.米氮平的分子盐和共晶体具有良好的物理化学性质。
J Pharm Biomed Anal. 2015 Jun 10;110:93-9. doi: 10.1016/j.jpba.2015.03.003. Epub 2015 Mar 12.
9
Physical stability enhancement of theophylline via cocrystallization.通过共结晶提高茶碱的物理稳定性
Int J Pharm. 2006 Aug 31;320(1-2):114-23. doi: 10.1016/j.ijpharm.2006.04.018.
10
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.使用戊二酸共晶体提高低溶解度活性药物成分的口服生物利用度。
Pharm Res. 2006 Aug;23(8):1888-97. doi: 10.1007/s11095-006-9032-3.

引用本文的文献

1
Application of cosolvency and cocrystallization approach to enhance acyclovir solubility.采用共溶剂法和共结晶法提高阿昔洛韦的溶解度。
BMC Chem. 2025 Jul 30;19(1):226. doi: 10.1186/s13065-025-01591-2.
2
Novel Gastroprotective and Thermostable Cocrystal of Dimethyl Fumarate: Its Preparation, Characterization, and and Evaluation.新型富马酸二甲酯胃保护和热稳定共晶体:其制备、表征及评价
ACS Omega. 2023 Jul 11;8(29):26218-26230. doi: 10.1021/acsomega.3c02463. eCollection 2023 Jul 25.
3
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
设计共晶体:一种解决原料药问题的合理共形成物选择方法。
Pharmaceutics. 2023 Apr 6;15(4):1161. doi: 10.3390/pharmaceutics15041161.
4
Non-Covalent Reactions Supporting Antiviral Development.支持抗病毒药物研发的非共价反应。
Molecules. 2022 Dec 19;27(24):9051. doi: 10.3390/molecules27249051.
5
Ketoprofen-FA Co-crystal: In Vitro and In Vivo Investigation for the Solubility Enhancement of Drug by Design of Expert.酮洛芬 FA 共晶:专家设计用于提高药物溶解度的体外和体内研究。
AAPS PharmSciTech. 2022 Mar 29;23(4):101. doi: 10.1208/s12249-022-02253-5.
6
Creation of Hydrochlorothiazide Pharmaceutical Cocrystals Via Hot-Melt Extrusion for Enhanced Solubility and Permeability.通过热熔挤出技术制备氢氯噻嗪药物共晶以提高其溶解度和渗透性。
AAPS PharmSciTech. 2022 Jan 18;23(1):56. doi: 10.1208/s12249-021-02202-8.
7
Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.大豆苷元共晶体:改善其生物药剂学参数的契机。
Heliyon. 2019 Nov 14;5(11):e02669. doi: 10.1016/j.heliyon.2019.e02669. eCollection 2019 Nov.